Peter L. Moses MD Biopharma Consultant, PLLC

Advanced Endoscopic Interventional

Professor Emeritus University of Vermont. Consultant for Biopharma and Life Sciences

37 Popple Dungeon RdCharlotte, VT 05445
Phone+1 802-425-4594

Dr. Moses is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Moses' full profile Already have an account?

Summary

Dr. Moses is a full professor Emeritus at the Robert Larner College of Medicine, University of Vermont. He is the former Medical Director at Takeda Pharmaceuticals and is actively consulting for Pharma Companies as a expert in the GI space.

Doctor Moses received his M.D. medical degree from Case Western Reserve University School of Medicine where he was elected to the Alpha-Omega-Alpha honor medical society. His post-graduate training in Internal Medicine, Gastroenterology and Hepatology was at Dartmouth Medical School and the Dartmouth Hitchcock Medical Center. He is the author of many peer reviewed articles in GI Medicine and Endoscopy.

Education & Training

MIT Sloane School of ManagementCertificate, Leadership Enterprise, 2009 - 2009
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Gastroenterology, 1995
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 1990 - 1993
Case Western Reserve University School of MedicineClass of 1990
Lake Forest CollegeB.A., with Honors, 1981

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

VT State Medical License 1991 - 2026
MA State Medical License 2021 - 2022
NY State Medical License 2009 - 2021
ABIM GI

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2014, 2016-2017

Clinical Trials

Fecal Microbiota Transplant in the Treatment of Ulcerative Colitis
UNKNOWN
EARLY_PHASE1
A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) Start of enrollment: 2018 Feb 27
COMPLETED
PHASE3
An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis Start of enrollment: 2018 Apr 04
COMPLETED
PHASE3

Publications & Presentations

PubMed

Early life exposure to broccoli sprouts confers stronger protection against enterocolitis development in an immunological mouse model of inflammatory bowel disease.
Lola Holcomb, Johanna M Holman, Molly Hurd, Brigitte Lavoie, Louisa Colucci
Msystems. 2023-12-21
10 citations
Steamed broccoli sprouts alleviate DSS-induced inflammation and retain gut microbial biogeography in mice.
Johanna M Holman, Louisa Colucci, Dorien Baudewyns, Joe Balkan, Timothy Hunt
Msystems. 2023-10-26
12 citations
Early life exposure to broccoli sprouts confers stronger protection against enterocolitis development in an immunological mouse model of inflammatory bowel disease.
Lola Holcomb, Johanna M Holman, Molly Hurd, Brigitte Lavoie, Louisa Colucci
Biorxiv. 2023-07-04

Journal Articles

Partially covered self-expandable metal stents versus polyethylene stents for malignant biliary obstruction: A cost effectiveness analysis
AN Barkum, V Adam, M Martel, K AlNaamani, PL Moses, Canadian Journal of Gastroenterology and Hepatology, 1/1/2015
Partially covered self-expandable metal stents vs plastic stents for malinent bilary obstruction: Acost-effectiveness analysis
Barkun,A, Martel, M, Alnaamani and Moses, PL, Can Journal of Gastroenter and Hepatology, 1/1/2015
Randomized trial in malignant biliary obstruction: Plastic vs partially covered metal stents
Moses, PL, Martel, M, Alnaamani, A, Stuart, G, Adam, V, Kowalski, T, Mitty, R, Barkun,A, Branch, MS, World Journal of Gastroenterology, 1/1/2013

Books/Book Chapters

Textbook of Gastroenterology
Chapter: Motility of the Biliary Tract
Page 264 - 283Mawe, GM., Moses, PL., Trevesani, G., Pozo, M.2009
Textbook of Gastroenterology
Chapter: Motility of the Biliary Tract. Chapter 12
Mawe GM, Moses PL, Pozo MJEditors: T. Yamada.Lippincott Williams and WilkinsEdition 4th,2003

Abstracts/Posters

Cost effectiveness of partially covered self-expandable metal stents vs. Polyethylene stents for malignant biliary obstruction.
Moses PL, Annual Scientific Meeting of the AGA, Chicago, IL, 1/1/2013
Mucosal serotonin signaling is altered in chronic constipation.
Costedio MM, Moses PL, Brooks E, Glass L, Wood M, Ganguly EK, Coates MD, Speer C, Hyman NH, Mawe GM, Annual AGA Meeting, 1/1/2008
Altered Intestinal Serotonin Signaling in Opiate-Induced Constipation.
Coates MD, Costedio MM, Ganguly EK, Callahan MJ, Mawe GM, Moses PL, American Journal of Gastroenterology; Annual Scientific Meeting of the American College of Gastroenterology, 1/1/2006

Lectures

FMT in Ulcerative colitis MIT/Finch/OpenBiome
Cambridge, MA - 1/1/2017
Serotonin signaling in the human gut.
Cambridge, MA - 1/1/2017
Manipulating the Gut Microbiota: Therapeutic Potential for Treatment of C. Difficile and Other GI Disorders.
Nashua, NH - 1/1/2017

Other

Discoveries and Breakthroughs Inside Science.
Moses PL, Syndicated TV Broadcast: ABC
Los Angeles, CA - 1/11/2004
Atypical Serotonin Concentrations found in Patients with IBS and Ulcerative Colitis – First Molecular Marker for Functional Bowel Disorders Identified
Moses PL, Gastroenterology and Endoscopy News
1/1/2004
Featured Article: While Poorly Understood, IBS is uniquely suited to DM Intervention.
Moses PL, Managed Healthcare Executive Shelley Rose
1/1/2004